High Level Pharmaceutical Forum 2005 - 2008 Final Report

(PDF, 955.3 ko)

In its Conclusions on Medical Products and Public Health of 2000, the Council of Ministers underlined the importance of identifying innovative medicines with significant added therapeutic value to attain both industrial and public health sector goals. In this spirit, a High Level Group on Innovation and Provision of Medicines (called “G10 Medicines”) was set up by the Commission to take a fresh look at the problems facing the pharmaceutical sector. The G10 Group presented its report in May 2002 in which it set out 14 wide-ranging recommendations. In 2003, the European Commission published the Communication1 “a stronger European-based pharmaceutical industry for the benefit of the patient - a call for action” in response to the G10 Group’s Recommendations. In order to tackle some of these recommendations, the Commission created the Pharmaceutical Forum in 2005 to take the process forward around three key themes : information to patients on pharmaceuticals ; pricing policy ; and relative effectiveness.